Skip to main navigation
  • Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
VectivBio

VectivBio

Transforming Lives

Site - Header Menu

  • About Us
    • Management Team
    • Board Members
    • Investors
    • Partners
  • Our Focus
    • Our Science
    • Our Pipeline
    • Our Clinical Trials
  • Investors & Media
    • Overview
    • News & Media
    • Events & Presentations
    • Annual General Meeting
    • Financial Information
    • Stock Information
    • Corporate Governance
    • Shareholder Resources
  • Contact Us
    • Careers

SEC Filings

Filing date Form Description Filing Group View
Jun 28, 2022 SC 13D/A

An amendment to a SC 13D filing

Other
0001104659-22-075228.pdf
0001104659-22-075228.rtf
View HTML
Jun 17, 2022 SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
0000929638-22-001049.pdf
0000929638-22-001049.rtf
0000929638-22-001049.xls
View HTML
Jun 16, 2022 424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

Registration Statements
0001628280-22-017293.pdf
0001628280-22-017293.rtf
0001628280-22-017293.xls
View HTML
Jun 16, 2022 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
0001628280-22-017382.pdf
0001628280-22-017382.rtf
0001628280-22-017382.xls
View HTML
Jun 14, 2022 424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

Registration Statements
0001628280-22-017122.pdf
0001628280-22-017122.rtf
0001628280-22-017122.xls
View HTML
Jun 13, 2022 F-3

Registration statement for certain foreign private issuers offered for certain transactions

Registration Statements
0001836379-22-000012.pdf
0001836379-22-000012.rtf
0001836379-22-000012.xls
View HTML
Jun 9, 2022 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
0001836379-22-000009.pdf
0001836379-22-000009.rtf
0001836379-22-000009.xls
View HTML
May 12, 2022 EFFECT

EFFECT

Other
9999999995-22-001446.pdf
9999999995-22-001446.rtf
9999999995-22-001446.xls
View HTML
May 6, 2022 CORRESP

CORRESP

Other
0001836379-22-000004.pdf
0001836379-22-000004.rtf
View HTML
May 6, 2022 UPLOAD

UPLOAD

Other
0000000000-22-004989.pdf
0000000000-22-004989.rtf
View HTML

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Next page Next ›
  • Last page Last »

Data provided by Kaleidoscope.

Primary Sidebar

INVESTORS & MEDIA

  • Overview
  • News & Media
    • Press Releases
  • Events & Presentations
  • Annual General Meeting
  • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Reports
  • Stock Information
    • Historical Stock Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board Members
    • Committee Composition
  • Shareholder Resources
    • FAQs
    • Email Alerts
    • Contact IR
    • RSS Feeds

Site - Shareholder Tools

Email Alerts Print Search

IR CONTACT

ir@vectivbio.com

 

Footer

Site - Footer Menu Left

VectivBio

Site - Footer Menu Center

Terms of Use Privacy Policy

Copyright © VectivBio AG, 2022. All Rights Reserved.

Site - Footer Menu Right

  • About Us
  • Our Focus
  • Investors & Media
  • Contact Us

Site - Header Menu

  • About Us
    • Management Team
    • Board Members
    • Investors
    • Partners
  • Our Focus
    • Our Science
    • Our Pipeline
    • Our Clinical Trials
  • Investors & Media
    • Overview
    • News & Media
    • Events & Presentations
    • Annual General Meeting
    • Financial Information
    • Stock Information
    • Corporate Governance
    • Shareholder Resources
  • Contact Us
    • Careers